BIA
What the life sciences industry wants from the next UK government
June 1, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, UK, general election, life sciences
The stakes are high as the UK general election draws ever closer, and the industry has come out in force …
BioIndustry Association calls for governmental support ahead of UK general election
May 2, 2017Manufacturing and Production, Sales and Marketing BIA, general election
In the run-up to the UK’s general election in June, government spending within the life sciences industry has become a …
Overcoming barriers in rare diseases
June 22, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, NHS, Shire, bates, government, nps, rare diseases
In recent months the focus on the need to develop new drugs and fund new treatments for rare diseases has …
After the UK general election, what’s next for pharma?
May 26, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA, election, medcity
In May the UK went to the polls and elected a Conservative government to replace the coalition that had been …
Funding boost for UK drugs manufacturing
March 30, 2015Manufacturing and Production, Sales and Marketing ABPI, AstraZeneca, BIA, Bristol-Myers Squibb, Britest, Cambridge, Cambridge Crystallographic Data Centre, GlaxoSmithKline, Perceptive Engineering, Pfizer, Process Systems Enterprise, UCB, University of Leeds, amsci, mmip, stfc
The UK government is funding new manufacturing partnerships that will improve design processes and supply chain initiatives to lift the …
Bioscience lab opens up in Cambridge
January 20, 2015Research and Development AstraZeneca, BIA, Babraham Research Campus, Cambridge, Menelas Pangalos
The UK Bennet Building bioscience laboratory doors have been opened during a ceremony at the Babraham Research Campus in Cambridge …
ABPI and BIA establish new manufacturing partnership
September 23, 2014Manufacturing and Production, Sales and Marketing ABPI, Actavis, AstraZeneca, BIA, Eisai, Fujifilm Diosynth Biotechnologies, GlaxoSmithKline, Knowledge Transfer Network (KTN), Oxford BioMedica, Pfizer, Whitehead, bates, mmip
The ABPI and the Bioindustry Association (BIA) have jointly established a new Medicines Manufacturing Industry Partnership (MMIP) to boost medicines …
Willetts champions UK life sciences
June 25, 2014Research and Development, Sales and Marketing BIA, BIO, Steve Bates, UK, Willetts, life sciences, san diego
Science minister David Willetts has been banging the drum for UK life sciences at a major conference in the US, …
£100 million funding stream aids UK biotech
June 23, 2014Research and Development, Sales and Marketing BIA, Steve Bates, biomedical catalyst, funding
UK biotech companies are developing new therapies for cancer, Parkinson’s, diabetes and tinnitus as a direct result of the £100 …
EMA launches speedy pilot
March 21, 2014Sales and Marketing BIA, EMA, MHRA, NICE, early access, trials
The European Medicines Agency (EMA) has launched an initiative aimed at speeding up the drug approval process and wants help …
BIA welcomes budget statement
March 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, Budget, Osborne, R&D, seed, sme
An increase in R&D tax credits and the creation of a cell therapy manufacturing centre were two of the highlights …
BIA ‘disappointed’ by early access funding
March 14, 2014Research and Development, Sales and Marketing BIA, NHS, bates, dams, early access
The BioIndustry Association (BIA) is ‘disappointed’ that the government is not funding the much-anticipated Early Access to Medicines Scheme (EAMS). …
UK agency urged to ‘press’ EMA on speed reviews
November 18, 2013Research and Development, Sales and Marketing BIA, EMA, EU, MHRA
A new advisory group for the UK drugs regulator wants Europe to follow the lead of the US by introducing …
UK is the go-to place for developing medicines
November 5, 2013Research and Development, Sales and Marketing BIA, Cell Medica, ReNeuron, UK
The BioIndustry Association (BIA) has said that the UK is clearly the must-go-to location for regenerative medicine research and development. …
